To Determine The Frequency Of Vitamin D Deficiency In Patients With Chronic Hepatitis C
DOI:
https://doi.org/10.51985/JBUMDC2018065Keywords:
Chronic Hepatitis C, Vitamin D deficiency, Liver CirrhosisAbstract
Objective: To determine the frequency of vitamin D deficiency in patients with chronic hepatitis C (CHC)
Design: It was a Descriptive and Cross Sectional study
Place and Duration of Study: It was carried out in the Medicine Unit of Pakistan Naval Ship SHIFA, Karachi from Nov
29, 2016 to May 29, 2017.
Patients and Methods: Approval was sought from Institutional Review Board before carrying out the study. Proper
history, clinical examination and appropriate lab investigations were carried out. Standard techniques were used for blood
sample collection. Site used for blood collection was antecubital fossa. Sterile method was used for fasting sample and
about 10 ml of blood was collected from each patient.
Results: A total of 289 patients were included. Strict exclusion and inclusion criteria was used for study cohort. Mean
age (years) of study cohort was 34.51+8.32. There were 188 (65.1) male and 101 (34.9) female patients. Patients with
CHC who were vitamin D deficient were 74 (25.6).
Conclusion: Patients of CHC had high frequency of vitamin D deficiency which suggests that further studies in the region
will be conduct in our general population to know the exact statistics which will pave the way for future researchers
References
Elgharably A, Gomaa AI, Crossey MM, Norsworthy PJ,
Waked I, Taylor-Robinson SD. Hepatitis C in Egypt–past,
present, and future. International journal of general medicine.
; 10:1.
Waheed Y. Hepatitis C eradication: a long way to go. World
J Gastroenterol. 2015; 21(43):12510-2.
Fleet JC, DeSmet M, Johnson R, Li Y. Vitamin D and cancer:
a review of molecular mechanisms. Biochem J. 2012;
(1):61-76.
Haines ST, Park SK. Vitamin D supplementation: what's
known what to do, and what's needed. Pharmacotherapy.
; 32(4):354-82.
Rahman AH, Branch AD. Vitamin D for your patients with
chronic hepatitis C? J Hepatol. 2013; 58(1):184-9.
Lappe J, Watson P, Travers-Gustafson D, Recker R, Garland
C, Gorham E, Baggerly K, McDonnell SL. Effect of vitamin
D and calcium supplementation on cancer incidence in older
women: a randomized clinical trial. Jama. 2017; 317(12):1234-
Mozos I, Marginean O. Links between vitamin D deficiency
and cardiovascular diseases. BioMed research international.
; 2015.
Villar LM, Del-Campo JA, Ranchal I, Lampe E, RomeroGomez M. Association between vitamin D and hepatitis C
virus infection: a meta-analysis. World J Gastroenterol. 2013;
(35):5917-24.
Roomi MA, Farooq A, Ullah E, Lone KP. Hypovitaminosis
D and its association with lifestyle factors. Pak J Med Sci.
; 31(5):1236-40. doi: 10.12669/pjms.315.7196.
Riaz H, Finlayson A, Bashir S, Hussain S, Mahmood S, Malik
F, et al. Prevalence of Vitamin D deficiency in Pakistan;
implications for the future. Expert Rev ClinPharmacol. 2015.
[Epub ahead of print]
Ladero JM, Torrejón MJ, Sánchez-Pobre P, Suárez A, Cuenca
F, de la Orden V, et al. Vitamin D deficiency and vitamin D
therapy in chronic hepatitis C. Ann Hepatol. 2013; 12(2):199-
Cholongitas E, Theocharidou E, Goulis J, Tsochatzis E,
Akriviadis E, Burroughs K. Review article: the extra-skeletal
effects of vitamin D in chronic hepatitis C infection. Aliment
PharmacolTher. 2012; 35(6):634-46.
Petta S, Grimaudo S, Tripodo C, Cabibi D, Calvaruso M, Di
Cristina A, Guarnotta C, Macaluso FS, Minissale MG,
Marchesini G, Craxì A. The hepatic expression of vitamin D
receptor is inversely associated with the severity of liver
damage in genotype 1 chronic hepatitis C patients. The Journal
of Clinical Endocrinology & Metabolism. 20151; 100(1):193-
Paternostro R, Wagner D, Reiberger T, Mandorfer M,
Schwarzer R, Ferlitsch M, Trauner M, Peck-Radosavljevic
M, Ferlitsch A. Low 25-OH-vitamin D levels reflect hepatic
dysfunction and are associated with mortality in patients with
liver cirrhosis. Wiener Klinische Wochenschrift. 2017; 129(1-
:8-15.
Kitson MT, Sarrazin C, Toniutto P, Eslick GD, Roberts SK.
Vitamin D level and sustained virologic response to interferonbased antiviral therapy in chronic hepatitis C: a systematic
review and meta-analysis. Journal of hepatology. 2014;
(6):1247-52.
Petta S, Cammà C, Scazzone C, Tripodo C, Di Marco V, Bono
A et al. Low vitamin D serum level is related to severe fibrosis
and low responsiveness to interferon-based therapy in genotype
chronic hepatitis C. Hepatology. 2010;51(4):1158-67.
Clark PJ, Thompson AJ, Vock DM, Kratz LE, Tolun AA,
Muir AJ et al. Hepatitis C virus selectively perturbs the distal
cholesterol synthesis pathway in a genotype-specific manner.
Hepatology. 2012; 56(1):49-56.
Ladero JM, Torrejón MJ, Sánchez-Pobre P, Suárez A, Cuenca
F, de la Orden V et al. Vitamin D deficiency and vitamin D
therapy in chronic hepatitis C. Ann Hepatol. 2013; 12(2):199-
Jin CN, Chen JD, Sheng JF. Vitamin D deficiency in hepatitis
C virus infection: what is old? What is new? European journal
of gastroenterology & hepatology. 2018; 30(7):741-6.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2018 Imran Hussain; M. Zill-e-Humayun Mirza; Ali Yusuf
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of Bahria University Medical & Dental College is an open access journal and is licensed under CC BY-NC 4.0. which permits unrestricted non commercial use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0 
